Alto Neuroscience (ANRO) Earnings Analysis

Alto Neuroscience (ANRO) next reports earnings on 2026-08-12, consensus EPS -0.71 USD. Last quarter (2026-03-16) it beat with EPS -0.45 USD vs -0.56 USD est (+19.6%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -10.98.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ANRO next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.71 USD
Revenue estimaten/a

ANRO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-16-0.45 USD-0.56 USD+19.6%Beat
2025-11-12-0.52 USD-0.66 USD+21.2%Beat
2025-08-13-0.65 USD-0.57 USD-14%Miss
2025-05-14-0.53 USD-0.59 USD+10.2%Beat
2025-03-20-0.56 USD-0.65 USD+13.8%Beat

Beat rate: 4/5 (80%) over reported quarters with consensus data.

ANRO valuation and analyst view

Trailing P/E-10.98
Trailing EPS-2.25902 USD
Price / book3.68
Dividend yield0.00%
Market cap0.96B
Analyst consensusBuy (8 buy / 1 hold / 0 sell)
Avg price target36.67 USD

Related research pages

Frequently asked questions

When is Alto Neuroscience (ANRO)'s next earnings date?

Alto Neuroscience is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.71 USD.

Did ANRO beat earnings last quarter?

In its 2026-03-16 report, ANRO posted EPS of -0.45 USD versus a -0.56 USD estimate — a beat of 19.6%.

What is ANRO's earnings track record?

Over the last 5 reported quarters with consensus data, ANRO beat estimates 4 times (80%).

What is ANRO's current P/E ratio and EPS?

ANRO trades at a trailing P/E of -10.98 on trailing EPS of -2.259021676344511 USD.

What do analysts rate ANRO?

Analyst consensus is "Buy" across 9 ratings (0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 36.67 USD.